Treasury4
United States
- Spokane, Washington
- 13/09/2023
- Series A
- $20,000,000
Treasury4 is an enterprise fintech creating advanced data analytics tools and solutions for corporate finance and treasury professionals. Our solutions are intuitive, easy to use, simple to navigate and built to provide easy access to the data you need when you need it.
- Industry Software Development
- Website https://www.treasury4.com/
- LinkedIn https://www.linkedin.com/company/treasury4/about/
Related People
Steve HelmbrechtCo Founder
United States -
Spokane-Coeur d'Alene Area
Experienced corporate executive with success delivering growth and results for companies ranging from entrepreneurial startups to publicly traded companies.
Executive and Sales Experience
Capital markets, investor relations, earnings releases and SEC reporting, M&A and deal negotiation, strategic planning, financial planning & analysis, cost management, tax planning, ERP, Treasury and financial systems, Sarbanes-Oxley. Extensive international experience. Successful in competing for large, winner-take-all Fintech software deals, both domestically and internationally.
Leadership Capabilities
Building and growing teams, mentoring and developing leaders. Executive sponsor of successful complex projects including global rollout of Oracle ERP system. Earned reputation for building trust internally and with third parties including external auditors, ratings agencies, sell-side analysts, commercial and investment bankers. Community leader with senior positions on multiple for-profit and nonprofit boards.
Leona Health | $14,000,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
Drive Health | $15,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)
Scylos | $3,000,000 | (Dec 18, 2025)
Last Energy | $100,000,000 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)